Ophthopedia Update: Experts examine FDA's review of SYD-101, genetic testing for myopia: In October 2025, the FDA issued a complete response letter to Sydnexis regarding SYD-101, an investigational formulation of low-dose atropine 0.01%. Despite achieving its primary… #ophthalmology #eye #eyenews

Ophthopedia Update: Panel examines myopia control spectacle lenses, pediatric imaging: The myopia epidemic continues to pose a significant international challenge, but the eye care community has made strides in reducing its progression in pediatric patients.
In… #ophthalmology #eye #eyenews

Ophthopedia Update: Governance key to balancing AI augmentation, risk for deskilling: An aircraft’s autopilot can guide every aspect of a flight, from takeoff to landing. But it is expected, and reassuring to know, that a pilot has the skills to intervene and assume… #ophthalmology #eye #eyenews

Ophthopedia Update: Q&A: How women physicians can find joy in personal finance: Brittne Halford, MD, MPH, paid off $138,000 in medical school debt in 2 years and 9 months without feeling (terribly) deprived of the good things in life.
“I am from a family that’s rich in… #ophthalmology #eye #eyenews

Ophthopedia Update: Case study: Claw-like part of insect found in lid abscess: The orbital septum is a thin fibrous membrane that separates the preseptal soft tissue from the postseptal orbital contents.
The septum begins at the orbital rim, where it attaches directly… #ophthalmology #eye #eyenews

Ophthopedia Update: Study shows long-term efficacy, safety of aflibercept 0.4 mg in ROP: VIENNA — Aflibercept 0.4 mg intravitreal injection in preterm and low birthweight infants with acute-phase retinopathy of prematurity was effective and well tolerated over 5 years… #ophthalmology #eye #eyenews

Ophthopedia Update: FDA clears investigational NDA for SZN-8141: Editor’s note: This is a developing story. Please check back soon for updates.
The FDA cleared an investigational new drug application for SZN-8141, a Wnt agonist and VEGF antagonist antibody designed to… #ophthalmology #eye #eyenews

Ophthopedia Update: Recruit for excellence ‘first, foremost’ but community care matters: Diversity, equity and inclusion efforts in medical practice are not just about reaching underserved communities but should also influence who is recruited to care for them.… #ophthalmology #eye #eyenews

Ophthopedia Update: Neurotrophic keratitis: Management strategies across the spectrum: Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics… #ophthalmology #eye #eyenews

Ophthopedia Update: New classification may standardize surgical site management: Researchers developed and validated a new classification system that may standardize reporting of all relevant grades of clinical presentation and management of surgical site outcomes,… #ophthalmology #eye #eyenews

Ophthopedia Update: SpyGlass Pharma acquires Advanced Vision Science: SpyGlass Pharma announced the acquisition of Advanced Vision Science in an effort to boost its IOL manufacturing capacity, according to a press release.
SpyGlass acquired all outstanding stock of… #ophthalmology #eye #eyenews

Ophthopedia Update: Q&A: How to build a nontraditional career as a physician: Growing up, Naomi Lawrence-Reid, MD, always knew she wanted to be a doctor.
Her career as a physician looks different from what she pictured as a medical student, but she said she wouldn’t… #ophthalmology #eye #eyenews

Ophthopedia Update: ECO-CAIRS represents evolution in use of allogenic ring segments: The management of keratoconus has evolved substantially over 3 decades.
While corneal transplantation was historically the only surgical option for advanced disease, intracorneal ring… #ophthalmology #eye #eyenews

Ophthopedia Update: HHS launches initiatives to make clinical trials faster: HHS launched a multi-component effort intended to improve the speed and efficiency with which clinical trials are conducted.
The series of initiatives is designed to eliminate duplication,… #ophthalmology #eye #eyenews

Ophthopedia Update: 4D-150 shows safety, vision gains in diabetic macular edema: In part one of the SPECTRA clinical trial, 4D-150, an intravitreal gene therapy, demonstrated positive safety outcomes as well as vision gains and central subfield thickness reduction in… #ophthalmology #eye #eyenews

Ophthopedia Update: Q&A: A 5-step approach to setting achievable goals: CHICAGO — SMART goals — an approach centered on making objectives specific, measurable, achievable, relevant and time-bound — provide a useful framework for personal growth, a speaker at the Women… #ophthalmology #eye #eyenews

Ophthopedia Update: FDA to remove references to animal testing in safety regulations: The FDA has issued a final rule that would remove references to animal studies in its drug safety regulations, as part of a larger effort across HHS to reduce what it calls… #ophthalmology #eye #eyenews

Ophthopedia Update: How women can step into leadership roles in medicine: CHICAGO — According to WHO, women represent 67% of the global health and social care workforce, providing essential health services to approximately 5 billion people worldwide.
However, research… #ophthalmology #eye #eyenews

Ophthopedia Update: Ophthalmology Foundation focuses on blindness worldwide: Preventing blindness worldwide requires teamwork between industry veterans and ophthalmologists who are willing to offer their time to strengthen education across the globe. The Ophthalmology… #ophthalmology #eye #eyenews

Ophthopedia Update: Ophthalmology Foundation focuses on blindness worldwide: Preventing blindness worldwide requires teamwork between industry veterans and ophthalmologists who are willing to offer their time to strengthen education across the globe. The Ophthalmology… #ophthalmology #eye #eyenews